Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T-lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines

Journal of Virology

Volumn 75, Issue 18, 2001, Pages 8681-8689

  Kaslow, R A ^a   Rivers, C ^a   Tang, J ^a   Bender, T J ^a   Goepfert, P A ^a   El Habib, R ^a   Weinhold, K ^a   Mulligan, M J ^a   Clements Mann, M L ^a   Schwartz, D ^a   Belshe, R ^a   Gorse, G ^a   Frey, S ^a   Dolin, R ^a   Keefer, M ^a   Evans, T ^a   Corey, L ^a   McElrath, J ^a   Graham, B ^a   Wright, P ^a   Spearman, P ^a   more..

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALVAC HIV RECOMBINANT CANARYPOX VACCINE; GAG PROTEIN; HLA ANTIGEN CLASS 1; HLA B27 ANTIGEN; HLA B57 ANTIGEN; RECOMBINANT VACCINE; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

ARTICLE; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; DNA POLYMORPHISM; DRUG RESPONSE; HLA SYSTEM; HOMOZYGOSITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; VACCINATION;

ADOLESCENT; ADULT; AIDS VACCINES; ALLELES; AVIPOXVIRUS; DOUBLE-BLIND METHOD; GENES, MHC CLASS I; GENETIC VECTORS; HAPLOTYPES; HIV INFECTIONS; HIV-1; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-C ANTIGENS; HOMOZYGOTE; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; PROGNOSIS; RISK FACTORS; RISK-TAKING; SEXUAL BEHAVIOR; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, SYNTHETIC;

EID: 0034886611     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.18.8681-8689.2001     Document Type: Article

References (56)

1. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia
2. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination
3. Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers
4. Approaches to improve engineered vaccines for human immunodeficiency virus and other viruses that cause chronic infections
5. Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand
6. Nomenclature for factors of the HLA system, 1998
7. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus
8. HLA and HIV-1: Heterozygosity advantage and B*35-Cw*04 disadvantage
9. Locus-specific amplification of HLA class I genes from genomic DNA: Locus-specific sequences in the first and third introns of HLA-A, and -C alleles
10. Immune responses to human immunodeficiency virus (HIV) type 1 induced by canarypox expressing HIV-1MN gp120, HIV-1SF2 recombinant gp120, or both vaccines in seronegative adults
11. HLA-B*5703 independently associated with slower HIV-1 disease progression in Rwandan women
12. Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef
13. A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers
14. Clade B-based vaccines elicit cross-clade T lymphocyte reactivities in uninfected volunteers
15. Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity
16. Effect of a single amino acid change in MHC class I molecules on the rate of progression of AIDS
17. HLA and other host factors in transfusion-acquired HIV-1 infection
18. Recombinant gp160 vaccination schedule and MHC HLA type as factors influencing cellular responses to HIV-1 envelope glycoprotein
19. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS
20. Differential narrow focusing of immunodominant human immunodeficiency virus Gag-specific cytotoxic T-lymphocyte responses in infected African and Caucasoid adults and children
21. Novel, cross-restricted, conserved and immunodominant epitopes. I. Slow progressors in HIV infection
22. Identification of a novel HLA-B*3501-restricted cytotoxic T lymphocyte epitope using overlapping peptides
23. Polymorphisms of the TAP2 gene may influence antibody response to live measles vaccine virus
24. New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS
25. HLA-B35 is associated with accelerated progression to AIDS
26. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques
27. Induction of vigorous cytotoxic T lymphocyte responses by live attenuated simian immunodeficiency virus
28. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection
29. Combinations of A1, Cw7, B8, DR3 HLA antigens associated with rapid decline of T-helper lymphocytes in HIV-1 infected homosexual men: A report from the Multicenter AIDS Cohort Study
30. HIV-1-specific mucosal CD8(+) lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi
31. The role of host genetics in the natural history of HIV-1 infection: The needles in the haystack
32. Consistent associations of HLA class I and class II and transporter gene products with progression of human immunodeficiency virus-1 infection in homosexual men
33. Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses
34. The role of cytotoxic T lymphocytes in the evolution of genetically stable viruses
35. Kinetics of gag-specific cytotoxic T lymphocyte responses during the clinical cohorts of HIV-infection: A longitudinal analysis of rapid progressors and long-term asymptomatics
36. Temporal association of cellular immune responses with the initial control of yiremia in primary human immunodeficiency virus type 1 syndrome
37. The immune response to hepatitis B vaccine in humans: Inheritance patterns in families
38. Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection
39. Combined genotypes of CCR5, CCR2, SDF1, and HLA genes can predict the long-term nonprogressor status in human immunodeficiency virus-1-infected individuals
40. HIV type 1 vaccine-induced cytotoxic T cell responses in phase I clinical trials: Detection, characterization, and quantitation
41. Association of HLA types A1-B8-DR3 and B27 with rapid and slow progression of HIV disease
42. T-cell depletion on virus replication in rhesus macaques immunized with a live, attenuated siminan immunodeficiency virus vaccine
43. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors
44. Human trials of HIV-1 vaccines
45. Frequency of HLA allele-specific peptide motifs in HIV-1 proteins correlates with the allele's association with relative rates of disease progression after HIV-1 infection
46. Env-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV contaminated body fluids
47. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors
48. HLA antigens associated with susceptibility/resistance to HIV-1 infection
49. Broadly cross-reactive HIV-specific cytotoxic T-lymphocytes in highly-exposed persistently seronegative donors
50. Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi
51. Simian immunodeficiency virus (SIV)-specific CTL are present in large numbers in livers of SIV-infected rhesus monkeys
52. Immunization with a modified vaccinia virus expressing simian immunodeficiency virus (SIV) Gag-Pol primers for an anemnestic Gagspecific cytotoxic T-lymphocyte response and is associated with reduction of viremia after SIV challenge
53. HLA class I homozygosity accelerates disease progression in human immunodeficiency virus type 1 infection
54. Sequence-based typing provides a new look at HLA-C diversity
55. Direct visualization of HIV-1-specific cytotoxic T lymphocytes during primary infection